FSCN1 and non-small cell lung carcinoma: Importantly, miRNA-145 was reported to target fascin and inhibit metastasis or invasion in many cancer types including colorectal [42], nasopharyngeal [43], gastric [44] and non-small-cell lung cancer [45].